Marc Hertz

Company: GRI Bio

Job title: President & CEO

Seminars:

Leveraging the Power of NKT Cell Targeting for Therapeutic Efficacy in Fibrotic Conditions 11:30 am

Innate-like adaptive Natural Killer T-cells that drive chronic inflammatory and fibrotic conditions NKT cells are elevated in patients with fibrosis, regulate the activity of both adaptive and innate immune responses, and are associated with progressive disease NKT cells are upstream of many of many of the key targets in fibrotic diseaseRead more

day: Day Two

Forget Fibroblasts? Examining Fibrosis as a Process & the Cell Types Beyond Fibroblasts that Play a Role in Driving Fibrosis 9:05 am

This interactive workshop provides a comprehensive understanding of fibrosis as a multifaceted process, highlighting the role of various cell types beyond fibroblasts including granulocytes, NK cells, neutrophils and beyond. By examining the contributions of different cellular players and their interactions, explore novel therapeutic targets and strategies to address fibrosis across different indications. Delve into: Understanding…Read more

day: Pre-Conference Day